Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Albinism”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Ended earlyNCT00467831
What this trial is testing

Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

Who this might be right for
Hermansky-Pudlak Syndrome (HPS)Pulmonary FibrosisOculocutaneous Albinism+2 more
National Human Genome Research Institute (NHGRI) 3
Not applicableStudy completedNCT02368340
What this trial is testing

A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Who this might be right for
Hermansky Pudlak Syndrome
Vanderbilt University 55
Not applicableUnknownNCT00006056
What this trial is testing

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

Who this might be right for
Chediak-Higashi SyndromeGraft Versus Host DiseaseX-Linked Lymphoproliferative Syndrome+3 more
Fairview University Medical Center 40
Not applicableStudy completedNCT04658381
What this trial is testing

Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population

Who this might be right for
Fovea PlanaAlbinism
Fondation Ophtalmologique Adolphe de Rothschild 20
Not applicableEnrolling By InvitationNCT06330324
What this trial is testing

Reproductive Options in Inherited Skin Diseases

Who this might be right for
IchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more
Maastricht University Medical Center 650
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Post-approval studies (Phase 4)UnknownNCT01377077
What this trial is testing

Punchgrafting Techniques for Vitiligo

Who this might be right for
Non-segmental VitiligoSegmental VitiligoPiebaldism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Not applicableStudy completedNCT02200263
What this trial is testing

The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism

Who this might be right for
Ocular Albinism (OA)Oculocutaneous Albinism (OCA)
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT01126814
What this trial is testing

Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

Who this might be right for
Leukemia
University Health Network, Toronto 35
Not applicableStudy completedNCT00005933
What this trial is testing

Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders

Who this might be right for
Chediak Higashi SyndromeChronic Granulomatous DiseaseJob's Syndrome+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Large-scale testing (Phase 3)Study completedNCT00814073
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 135
Not applicableStudy completedNCT00808106
What this trial is testing

Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism

Who this might be right for
Oculocutaneous Albinism
National Human Genome Research Institute (NHGRI) 206
Large-scale testing (Phase 3)Not Yet RecruitingNCT05970900
What this trial is testing

Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST

Who this might be right for
Gastrointestinal Stromal Tumor of Rectum
Fujian Medical University Union Hospital 23
Not applicableStudy completedNCT05544578
What this trial is testing

Korean Translation and Validation of the K-HEPI in NYC

Who this might be right for
DisasterVulnerable Populations
Hunter College of City University of New York 400
Not applicableStudy completedNCT03959605
What this trial is testing

Genetic Determinant of Foveolar Hypoplasia in Parents of Albinos Children

Who this might be right for
Albinism, Ocular
Fondation Ophtalmologique Adolphe de Rothschild 48
Testing effectiveness (Phase 2)Study completedNCT00730314
What this trial is testing

Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Sickle Cell DiseaseThalassemiaAnemia+9 more
Children's Hospital Los Angeles 25
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT01838655
What this trial is testing

Nitisinone for Type 1B Oculocutaneous Albinism

Who this might be right for
AlbinismVision Loss
National Eye Institute (NEI) 5
Load More Results